BROWSE BY
0
Avadel Pharmaceuticals plc Banner Image

Avadel Pharmaceuticals plc

  • Ticker AVDL
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Other More
  • Sector Healthcare More
Avadel Pharmaceuticals plc Logo Image
  • 11-50 Employees
  • Based in Dublin, Ireland
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is an emerging biopharmaceutical company. The Company’s primary focus is the development and potential FDA approval of FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy.
Visit website
REPORT RATINGS
4.7 / 5.0 (106)

Avadel Pharmaceuticals plc reports have an aggregate usefulness score of 4.7 based on 106 reviews.

Avadel Pharmaceuticals plc

Most Recent Annual Report

Avadel Pharmaceuticals plc
MOST RECENT 2025 Annual Report
View PDF

View 2025 Corporate Responsibility Report

This company has a Corporate Responsibility Report available to view on our partner site, ResponsibilityReports.com

Older/Archived Annual Reports

Show 6 older reports
x
Avadel Pharmaceuticals plc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!